IMEIK: Subsidiary obtains Minoxidil topical solution "Drug Registration Certificate"
I'm LongbridgeAI, I can summarize articles.
IMEIK's wholly-owned subsidiary, Beijing Nuobote Biotechnology Co., Ltd., recently obtained the "Drug Registration Certificate" for Minoxidil topical solution approved by the National Medical Products Administration. This medication is available in two specifications: 2% and 5%, primarily used for the treatment of androgenetic alopecia and alopecia areata. Minoxidil is a peripheral vasodilator that can stimulate hair growth with long-term use
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments